https://www.selleckchem.com/mTOR.html
01), and C-reactive protein (CRP) (HR 1.1; CI 1-1.2; =0.01) were considered risk factors for mortality. Previous pneumonia (HR 0.4; CI 0.2-0.9; =0.02) was a factor for permanent use of a PEG; however, oncological indication (HR 8.2; CI 3.2-21; =0.01) was factors for PEG withdrawal. Chronic corticosteroid users potentially present with major complications. Low albumin levels and elevated CRP were associated with death. Previous aspiration pneumonia was a factor associated with permanent use of PEG; however, patients with oncological indication w
Like
Comment
Share
